• Working with an industry veteran and mentor 7 months, I conducted market sizing estimates for my client, CellCue Bio. These estimates are still being used in their non-confidential pitchdeck after my departure.
• I received hands-on formal training in pitch-deck building, storytelling, presentation, and pitching.  
• I received training in systematically implementing Justice Diversity Equity & Inclusion (JEDI) principles in business frameworks.
• I participated in drafting Cellcue Bio’s diversity statement.
• Through guidance of industry mentors affiliated with Nucleate, I gained exposure to diverse regulatory strategies, fundraising strategy, technical de-risking, & market risk identification.

• I gave a competitive pitch to an audience of world-renowned venture-capital judges at Pillar VC, Harvard and MIT academics and industry veterans.

Emory Biotech Consulting
Pro bono Consultant *NDA
8.22-12.22

• Our client invented a class II MedTech device and sought consulting on a comprehensive go to market strategy, value analysis, and funding acquisition strategy.
• Working within a team, I conducted market analysis to compare the volume, growth, sales price, and market size for several possible indications for their device.
• Based on my market analysis, I nominated the most economically and clinically valuable indication for use by my client’s devide.
• I strategized regulatory and financial opportunities for our client. I identified clinical precedence for legacy devices pursuing the 510K pathway. My market analyses identified private equity financing as most strategic for their specific device.
• Working in a team, I gave a competitive pitch to the Atlanta biotech community on behalf of our client.

Emory Biotech Consulting
Pro bono Consultant *NDA
1.22-5.22

• I consulted a clinician on bringing their combination drug-device to market.
• I worked with a patent lawyer to evaluate the freedom to operate with their device, as well as nominating the most competitive regulatory pathway through the FDA.
• I identified and communicated market and technical risks pertinent to our client.
• I nominated that our client pursue the Investigational New Drug (IND) pathway for their combination drug-device. This nomination cut the total application costs in half.

Emory University, Graduate Neuroscience Program
Teaching Assistant
8.19-12.19

• I assisted with organizing, communicating with, and coordinating the guest lecturers and senior faculty.
• I reviewed, graded, and communicated with Y1 Neuroscience graduate students on the development of their Curriculum Vitae.
• I taught a 1-hour long lecture on how to use reference management software and a brief lecture on giving elevator pitches.